Cargando…
Selective estrogen receptor modulator (SERM) for the treatment of osteoporosis in postmenopausal women: focus on lasofoxifene
Selective estrogen receptor modulators (SERMs) represent a class with a growing number of compounds that act as either estrogen receptor agonists or antagonists in a tissue-specific manner. This article reviews lasofoxifene, a new-generation SERM that has completed phase III development for the prev...
Autores principales: | Gennari, Luigi, Merlotti, Daniela, Nuti, Ranuccio |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2817938/ https://www.ncbi.nlm.nih.gov/pubmed/20169039 |
Ejemplares similares
-
Lasofoxifene: Evidence of its therapeutic value in osteoporosis
por: Gennari, Luigi, et al.
Publicado: (2010) -
Bazedoxifene for the prevention of postmenopausal osteoporosis
por: Gennari, Luigi, et al.
Publicado: (2008) -
Lasofoxifene for the prevention and treatment of postmenopausal osteoporosis
por: Lewiecki, E Michael
Publicado: (2009) -
New Selective Estrogen Receptor Modulators (SERMs) in Development
por: Silverman, Stuart L.
Publicado: (2010) -
The differential effects of bisphosphonates, SERMS (selective estrogen receptor modulators), and parathyroid hormone on bone remodeling in osteoporosis
por: Migliaccio, Silvia, et al.
Publicado: (2007)